Search Results | Blood | American Society of Hematology

1-20 of 44

2 3

Sort by

Sort Order Select

Journal Articles

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients

Alexis Maillard, Rabah Redjoul, Marion Klemencie, Hélène Labussière Wallet, Amandine Le Bourgeois, Maud D'Aveni, Anne Huynh, Ana Berceanu, Tony Marchand, Sylvain Chantepie, Carmen Botella Garcia, Michael Loschi, Magalie Joris, Cristina Castilla-Llorente, Anne Thiebaut-Bertrand, Sylvie François, Mathieu Leclerc, Patrice Chevallier, Stephanie Nguyen

Blood (2022) 139 (1): 134–137.

DOI: https://doi.org/10.1182/blood.2021014232

Published: 2022

Includes: Supplemental data

Journal Articles

Allogeneic Stem Cell Transplantation for Patients with Acute Myelogenous Leukemia (AML) in Second Complete Remission (CR2) Transplanted from Unrelated Donors with Post Transplant Cyclophosphamide (PTCy). a Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Arnon Nagler, Myriam Labopin, Aleksandr D. Kulagin, Hélène Labussière-Wallet, Montserrat Rovira, Didier Blaise, Jan Vydra, Ibrahim Yakoub-Agha, Goda Choi, Yener Koc, Péter Reményi, Fabio Ciceri, Jaime Sanz, Mohamad Mohty

Blood (2021) 138 (Supplement 1): 3916.

DOI: https://doi.org/10.1182/blood-2021-144894

Published: 2021

Journal Articles

Umbilical Cord Blood Transplantation after Graft Failure from a Previous Hematopoietic Stem Cell Transplantation

Fernanda Volt, Annalisa Ruggeri, Graziana Maria Scigliuolo, Regis Peffault De Latour, Marc Bierings, Amal Al-Seraihy, Henrique Bittencourt, Helene Labussiere-Wallet, Vanderson Rocha, Chantal Kenzey, Barbara Cappelli, Hanadi Rafii, Eliane Gluckman, Renato Luiz Guerino-Cunha

Blood (2021) 138 (Supplement 1): 1785.

DOI: https://doi.org/10.1182/blood-2021-145287

Published: 2021

Journal Articles

Final Long-Term Results from the Defifrance Registry Study: Efficacy and Safety of Defibrotide for the Treatment of Severe/Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation

Mohamad Mohty, Didier Blaise, Regis Peffault De Latour, Myriam Labopin, Marie Detrait, Stephane Girault, Anne Huynh, Hélène Labussière-Wallet, Thierry Lamy, Delphine Lebon, Sébastien Maury, Cecile Renard, Kobby Asubonteng, Floriane Delaval, Ibrahim Yakoub-Agha, Jean-Hugues Dalle

Blood (2021) 138 (Supplement 1): 1789.

DOI: https://doi.org/10.1182/blood-2021-147302

Published: 2021

Journal Articles

Outcome of Human Umbilical Cord Blood Stem Cell Transplantation (CBT) for Acute Myeloid Leukemia in Patients Achieving First Complete Remission after One Versus Two Induction Courses: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Arnon Nagler, Myriam Labopin, Jan J. Cornelissen, Edouard Forcade, Patrice Chevallier, Nathalie Fegueux, Jorge Sierra, Hélène Labussière-Wallet, Jennifer Byrne, Thomas Cluzeau, Didier Blaise, Frédéric Baron, Annalisa Ruggeri, Mohamad Mohty, Deborah Desmier

Blood (2021) 138 (Supplement 1): 3964.

DOI: https://doi.org/10.1182/blood-2021-144827

Published: 2021

Journal Articles

Pooled Allogenic Fecal Microbiotherapy MaaT013 for the Treatment of Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Phase IIa Heracles Study and Expanded Access Program

Blood (2021) 138 (Supplement 1): 262.

DOI: https://doi.org/10.1182/blood-2021-147709

Published: 2021

Journal Articles

Characteristics and Outcomes of Newly Diagnosed Multiple Myeloma Patients with and without Extramedullary Disease after Autologous Transplant and Maintenance Therapy: A Study from the Cmwp-EBMT

Blood (2021) 138 (Supplement 1): 485.

DOI: https://doi.org/10.1182/blood-2021-152391

Published: 2021

Journal Articles

Higher Efficacy of TBI + Cyclophosphamide Than TBI + Fludarabine As Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia: An Analysis By the Acute Leukemia Working Party of the EBMT

Blood (2021) 138 (Supplement 1): 2876.

DOI: https://doi.org/10.1182/blood-2021-151000

Published: 2021

Journal Articles

Outcomes of Allogeneic Hematopoietic Cell Transplantation with Cord Blood Versus Mismatched Unrelated Donor with Post-Transplant Cyclophosphamide in Acute Myeloid Leukemia: An Analysis from the ALWP of the EBMT

Bhagirathbhai Dholaria, MBBS, Myriam Labopin, MD, Jaime Sanz Caballer, MD PhD, Annalisa Ruggeri, MD, Jan J. Cornelissen, MD PhD, Hélène Labussière-Wallet, Didier Blaise, MD, Edouard Forcade, MD, Patrice Chevallier, MD PhD, Anna Grassi, MD, Ludmila S Zubarovskaya, MD PhD professor, Jurgen H.E. Kuball, MD PhD, Patrice Ceballos, MD PhD, Fabio Ciceri, MD, Bipin N. Savani, MD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2020) 136 (Supplement 1): 5–6.

DOI: https://doi.org/10.1182/blood-2020-139362

Published: 2020

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 45.

DOI: https://doi.org/10.1182/blood-2019-124765

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Francesco Saraceni, Myriam Labopin, MD, Edouard Forcade, MD, Nicolaus Kröger, Gerard Socie, MD PhD, Riitta Niittyvuopio, Jan J Cornelissen, MD PhD, Hélène Labussière-Wallet, Didier Blaise, MD PhD, Goda Choi, MD PhD, Jenny Byrne, MD PhD, Gaëlle Guillerm, MD, Thierry Lamy, PhD MD, Jordi Esteve, Ali Bazarbachi, MD PhD, Bipin N. Savani, MD, Arnon Nagler, MD MSc, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 2038.

DOI: https://doi.org/10.1182/blood-2019-127713

Published: 2019

Journal Articles

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical Sibling Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 148.

DOI: https://doi.org/10.1182/blood-2019-123269

Published: 2019

Journal Articles

Underdiagnosed Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome(VOD/SOS) As a Major Cause of Multi-Organ Failure in Acute Leukemia Transplant Patients: An Analysis from the EBMT Acute Leukemia Working Party

Blood (2019) 134 (Supplement_1): 4483.

DOI: https://doi.org/10.1182/blood-2019-124065

Published: 2019

Journal Articles

Inferior Outcome of Allogeneic Stem Cell Transplantation in First Complete Remission for Secondary AML As Compared to De Novo Disease: Results from a Retrospective, Registry-Based Analysis on Behalf of the Acute Leukemia Working Party of the EBMT

Christoph Schmid, MD, Myriam Labopin, MD, Gerard Socie, MD PhD, Maija Itälä-Remes, MD PhD, Didier Blaise, Ibrahim Yakoub-Agha, MD PhD, Noel Milpied, MD, Jan J Cornelissen, MD PhD, Arnold Ganser, MD, Dietrich W. Beelen, Hélène Labussière-Wallet, Jakob R. Passweg, MD MS, Bipin N. Savani, MD, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 2166.

DOI: https://doi.org/10.1182/blood-2018-99-113779

Published: 2018

Journal Articles

Allogeneic Stem Cell Transplantation from Unmanipulated Haploidentical Donors Versus Matched or Mismatched 9/10 Unrelated Donors in Acute Lymphoblastic Leukemia in First Complete Remission: On Behalf of the ALWP of the EBMT

Noga Shem-Tov, MD, Christophe Peczynski, Myriam Labopin, MD, Maija Itälä-Remes, MD PhD, Didier Blaise, Hélène Labussière-Wallet, Gérard Socié, MDPhD, Nicolaus Kröger, MD, Per Ljungman, MD PhD, Boris Afanasyev, Patrice Chevallier, MD, Johanna Tischer, Grzegorz Helbig, Pavel Jindra, MD PhD, Sebastian Giebel, Mohamad Mohty, MD PhD, Arnon Nagler, MD

Blood (2018) 132 (Supplement 1): 2174.

DOI: https://doi.org/10.1182/blood-2018-99-111604

Published: 2018

Journal Articles

Outcomes after Unrelated Cord Blood Transplantation (UCBT) in Patients with Chronic Myeloid Leukemia (CML): A Retrospective Study from the Cmwp-EBMT

Blood (2018) 132 (Supplement 1): 3475.

DOI: https://doi.org/10.1182/blood-2018-99-115977

Published: 2018

Journal Articles

The Role of Anti-Thymocyte Globulin (ATG) in Patients with AML Transplanted in CR1 from Sibling and Unrelated Donors with or without Measurable Residual Disease (MRD) at the Time of Allogeneic Stem Cell Transplantation: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Arnon Nagler, MD, Myriam Labopin, MD, Gerard Socie, MD PhD, Anne Huynh, MD, Maija Itälä-Remes, MD PhD, Eric Deconinck, MD PhD, Ibrahim Yakoub-Agha, MD PhD, Jean-Yves Cahn, MD, Jean-Henri Bourhis, Hélène Labussière-Wallet, Sylvain Chantepie, MD, Jordi Esteve, MD PhD, Mohamad Mohty, MD PhD

Blood (2018) 132 (Supplement 1): 248.

DOI: https://doi.org/10.1182/blood-2018-99-110279

Published: 2018

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients with Acute Myeloid Leukemia: Analysis of the Francophone Society for Stem Cell Transplantation and Cell Therapy

Regis Peffault De Latour, Matthieu Resche-Rigon, MD PhD, Didier Blaise, Johan Maertens, MD, Patrice Ceballos, MD, Patrice Chevallier, MD, Edouard Forcade, MD, Anne Huynh, MD, Pierre Simon Rohrlich, Helene Labussiere-Wallet, MD, Jacques-Olivier Bay, MD PhD, Yves Chalandon, MD PhD, Gerard Socie, MD PhD, Marie Thérèse Rubio, MD

Blood (2018) 132 (Supplement 1): 3447.

DOI: https://doi.org/10.1182/blood-2018-99-111710

Published: 2018

Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Richter's Syndrome:the SFGM-TC Experience

Blood (2018) 132 (Supplement 1): 3457.

DOI: https://doi.org/10.1182/blood-2018-99-117904

Published: 2018

Journal Articles

Haploidentical Transplantation Using High Dose Post-Transplant Cyclophosphamide for Patients with Aplastic Anemia : The European Group for Blood and Marrow Transplantation Experience

Blood (2018) 132 (Supplement 1): 486.

DOI: https://doi.org/10.1182/blood-2018-99-114033

Published: 2018

2 3

NARROW

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients

Umbilical Cord Blood Transplantation after Graft Failure from a Previous Hematopoietic Stem Cell Transplantation

Final Long-Term Results from the Defifrance Registry Study: Efficacy and Safety of Defibrotide for the Treatment of Severe/Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation

Outcome of Human Umbilical Cord Blood Stem Cell Transplantation (CBT) for Acute Myeloid Leukemia in Patients Achieving First Complete Remission after One Versus Two Induction Courses: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Pooled Allogenic Fecal Microbiotherapy MaaT013 for the Treatment of Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Phase IIa Heracles Study and Expanded Access Program

Characteristics and Outcomes of Newly Diagnosed Multiple Myeloma Patients with and without Extramedullary Disease after Autologous Transplant and Maintenance Therapy: A Study from the Cmwp-EBMT

Higher Efficacy of TBI + Cyclophosphamide Than TBI + Fludarabine As Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia: An Analysis By the Acute Leukemia Working Party of the EBMT

Outcomes of Allogeneic Hematopoietic Cell Transplantation with Cord Blood Versus Mismatched Unrelated Donor with Post-Transplant Cyclophosphamide in Acute Myeloid Leukemia: An Analysis from the ALWP of the EBMT

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Karnofsky Performance Status Score Equal or Lower Than 80%. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical Sibling Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT

Underdiagnosed Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome(VOD/SOS) As a Major Cause of Multi-Organ Failure in Acute Leukemia Transplant Patients: An Analysis from the EBMT Acute Leukemia Working Party

Inferior Outcome of Allogeneic Stem Cell Transplantation in First Complete Remission for Secondary AML As Compared to De Novo Disease: Results from a Retrospective, Registry-Based Analysis on Behalf of the Acute Leukemia Working Party of the EBMT

Allogeneic Stem Cell Transplantation from Unmanipulated Haploidentical Donors Versus Matched or Mismatched 9/10 Unrelated Donors in Acute Lymphoblastic Leukemia in First Complete Remission: On Behalf of the ALWP of the EBMT

Outcomes after Unrelated Cord Blood Transplantation (UCBT) in Patients with Chronic Myeloid Leukemia (CML): A Retrospective Study from the Cmwp-EBMT

Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients with Acute Myeloid Leukemia: Analysis of the Francophone Society for Stem Cell Transplantation and Cell Therapy

Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Richter's Syndrome:the SFGM-TC Experience

Haploidentical Transplantation Using High Dose Post-Transplant Cyclophosphamide for Patients with Aplastic Anemia : The European Group for Blood and Marrow Transplantation Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only